Issue link: http://osercommunicationsgroup.uberflip.com/i/808989
Chain Drugstore Daily Sunday, April 23, 2017 4 CURAD: NOT JUST FIRST AID ANYMORE The CURAD ® brand has been known for quality first aid since the 1950s. Today, the company continues to expand its selection of innovative medical solutions to help consumers feel and heal their best. Building on its rugged line of Performance Series bandages, the brand now offers a full line of Performance Series orthopedic supports, wraps and tapes. These products are designed and built to "turn setbacks into comebacks" with extraordinary durability and com- fort. Simple hook & loop fasteners pro- vide easy-to-use, customizable support to help support injuries – or prevent them. For work or play, Performance Series supports the most active people on the field, in the gym and on the job. This new line also reflects a new, redesigned CURAD branding initiative for greater impact at shelf. Even the shield-shaped CURAD logo has been redesigned to enhance the image of lead- ership, strength and protection. Bold packaging specifically for Performance Series products helps identify them as premium products at a glance. In addition to clear usage, feature and bene- fit information, each package aids the con- sumer with a clearly marked "support level" – Fixed, Firm and Flex. Fixed: Greater rigidity to help keep joints aligned with maximum support; superior padding for comfort; reinforced stress points for durability; most feature Microban™ antimicrobial protection. Firm: Medium support with soft, cush- ioned bracing for added comfort and CAMBER'S VERTICAL INTEGRATION AND EXPANSION IS KEY TO STRONG SUPPLY CHAIN Camber Pharmaceuticals parent compa- ny, Hetero Drugs of Hyderabad, India, is investing heavily in R&D and infrastruc- ture to keep pace with the expanding generics marketplace. Its research and development efforts are focused on more complex molecules, including oncology, ARVs, Hepatitis C and biosimilars. With more than 25 manufacturing facilities across the globe, including five plants in Special Economic Zones, Hetero can produce more than 50 billion oral doses annually. Hetero offers the largest campus of API reactor capacities in the world, allowing Camber to be ver- tically integrated on more than 90 percent of its product line. Currently, Hetero employs some 15,000 associates in more than 120 countries worldwide. New Facilities in the U.S. and India Increase Capacities At three different plants in India, Hetero has more than doubled its capacities, adding more than 1 million square feet to where the total m a n u f a c t u r i n g and warehouse space now exceeds 2.5 million square feet dedicated solely to the U.S. marketplace. In the United States, Hetero is building a new 310,000 square foot state-of-the-art man- ufacturing facility in Central Islip, New York, for Camber's sister company, Ascent Pharmaceuticals, which will open in June 2017. In addition, Hetero recent- ly purchased an existing 110,000 square foot facility close by in Long Island. Continued on Page 33 Continued on Page 33 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS Kimberly Oser Publisher Jules Denton Senior Associate Publisher Carlos Velasquez Associate Publisher Lorrie Baumann Editorial Director Jeanie Catron JoEllen Lowry Karrie Welborn Associate Editors Yasmine Brown Jonathan Schieffer Graphic Designers Caitlyn McGrath • Sarah Glenn Customer Service Managers Stacy Davis • Jay Watson Show Logistics & Distribution John Pechota Sales Floor Manager Marcos Morhaim Senior Account Manager Anthony Socci Account Manager Tara Neal Director of Operations Enrico Cecchi European Sales Chain Drugstore Daily is published by Oser Communications Group ©2017 All rights reserved. Executive and editorial offices at: 1877 N. Kolb Road, Tucson, AZ 85715 520.721.1300/Fax: 520.721.6300 European offices located at Lungarno Benvenuto Cellini, 11, 50125 Florence, Italy www.osercommunicationsgroup.com Lee M. Oser Founder